NASDAQ:BNR

Burning Rock Biotech Q2 2026 Earnings Results & Report

Burning Rock Biotech logo
$13.27 -0.05 (-0.38%)
Closing price 11/20/2026 03:58 PM Eastern
Extended Trading
$13.28 +0.02 (+0.11%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Burning Rock Biotech beat analyst expectations on both earnings and revenue in its Q2 2026 results, released September 10, 2026. The company reported EPS of -$0.20 versus the -$2.2883 consensus estimate, while revenue of $19.84 million topped the $19.21 million estimate by $630.03 thousand.

Earnings Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call
7:00 AM ET

Burning Rock Biotech EPS Results

Actual EPS
-$0.20
Consensus EPS
-$2.2883
Beat/Miss
Beat by +$2.0883
One Year Ago EPS
N/A

Burning Rock Biotech Revenue Results

Actual Revenue
$19.84 million
Expected Revenue
$19.21 million
Beat/Miss
Beat by +$630.03 thousand
YoY Revenue Growth
N/A

Upcoming Earnings

Burning Rock Biotech's Q3 2026 earnings is estimated for Monday, November 23, 2026, based on past reporting schedules, with a conference call scheduled on Friday, November 27, 2026 at 12:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

Burning Rock Biotech Q2 2026 Earnings FAQ

Burning Rock Biotech (NASDAQ:BNR) reported earnings of -$0.20 per share for Q2 2026, beating the consensus estimate of -$2.2883. The report was announced on Thursday, September 10, 2026.

Burning Rock Biotech reported revenue of $19.84 million for Q2 2026, against a consensus estimate of $19.21 million.

Burning Rock Biotech's next earnings date is estimated for Monday, November 23, 2026. MarketBeat tracks confirmed and estimated earnings dates for Burning Rock Biotech on the company's earnings history page.

Burning Rock Biotech Earnings Headlines

Burning Rock Biotech (BNR) versus Its Competitors Critical Analysis
Worse than socialism
Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel
Burning Rock Biotech (BNR) Projected to Release Earnings on Tuesday
See More Burning Rock Biotech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Burning Rock Biotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Burning Rock Biotech and other key companies, straight to your email.

About Burning Rock Biotech

Burning Rock Biotech (NASDAQ:BNR) is a precision oncology company that develops and provides next-generation sequencing tests for cancer. Its testing uses tissue and blood samples to help inform treatment decisions, monitor disease and support cancer research.

The company also provides research and clinical-trial services to pharmaceutical companies, including support for the development of cancer therapies and diagnostic tests. Burning Rock is headquartered in Guangzhou, China, and its business primarily serves the Chinese healthcare and life sciences markets.

Founded in 2014, Burning Rock focuses on applying genomic testing to cancer care, including the development of tests for treatment selection and disease monitoring.

View Burning Rock Biotech Profile